Table 2.

Final Model from Stepwise Selection Analysis for Inflammatory Biomarkers in Relation to CVD

Variable	Hazard Ratio	95% Confidence	Interval	Nominal P-Value
C-reactive protein	1.18	1.02	1.35	0.02
Tumor necrosis factor receptor II	1.15	1.01	1.32	0.04

The covariates included age, sex, current smoking, body mass index, systolic blood pressure, total/high density lipoprotein cholesterol, diabetes, and hypertension treatment. Prevalent major CVD were excluded from this analysis.

Hazard ratios are per one standard deviation increase in ln-biomarker concentration.